Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [145]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“non-ICU), presence of a central venous catheter, receipt of total parenteral nutrition (TPN) or mechanical ventilation at the onset of SAB, source of bacteremia, and severity of illness at the onset of SAB (as calculated on the basis of the APACHE II score [17]).”
MethodCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770 · cited 1×
“Only cases of SAB that occurred 2 days after hospital admission and that met the Centers for Disease Control and Prevention (CDC) criteria for bloodstream infection were included in the analysis [15].”
MethodIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[11] reported that patients who received inappropriate empirical therapy for bloodstream infections in the ICU were at an almost 7-fold higher risk of mortality, compared with patients who received adequate antimicrobial therapy.”
Background(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685 · cited 1×
“4%) of 398 patients with SAB did not receive appropriate therapy 48 h after the first positive blood culture result was obtained [9].”
BackgroundBoyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485 · cited 1×
“The widespread use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) infection has coincided with an increased incidence of vancomycinresistant enterococci (VRE) infections, and numerous studies have suggested an association between vancomycin use and the emergence of VRE [ 1-5].”
Background
Cited by
Items 201–300 of 650
Recent Developments in the Diagnosis and Management of Severe Sepsis
Wheeler, A. P. (2007) · CHEST Journal · doi:10.1378/chest.06-2535 · Cited by 46
Manzur, A., Vidal, M., Pujol, M., Cisnal, M., Hornero, A., Aumatell, C. M., Peña, C., Gudiol, F., & Ariza, J. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.03.015 · Cited by 46
Developing Quality Measures for Sepsis Care in the ICU
Berenholtz, S. M., Pronovost, P. J., Ngo, K., Barie, P. S., Hitt, J., Kuti, J. L., Septimus, E. J., Lawler, N. K., Schilling, L., & Dorman, T. (2007) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(07)33060-2 · Cited by 46
Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer
Jorgensen, S. C. J., Lagnf, A. M., Bhatia, S., Shamim, M.-D., & Rybak, M. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky452 · Cited by 45
Self-citationTime to Administration of Antibiotics among Inpatients with Severe Sepsis or Septic Shock
Mok, K., Christian, M. D., Nelson, S., & Burry, L. D. (2014) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v67i3.1358 · Cited by 45
“7 Sex, male 56 (56) Admitting service General medicine 51 (51) General surgery 19 (19) Intensive care unit 30 (30) Diagnosis Severe sepsis 60 (60) Septic shock 40 (40) Comorbidities Immunocompromise 19 (19) Cancer (active malignancy) 23 (23) Liver disease 11 (11) Heart failure 20 (20) COPD 10 (10) Renal failure 26 (26…”
BackgroundКirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Jalili, M., Barzegari, H., Pourtabatabaei, N., Honarmand, A. R., Boreiri, M., Mehrvarz, A., & Ahmadinejad, Z. (2013) · PubMed · Cited by 44
Carlton, H. C., Savović, J., Dawson, S., Mitchelmore, P. J., & Elwenspoek, M. M. C. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.05.018 · Cited by 44
Outcome for invasive Staphylococcus aureus infections
Jacobsson, G., Gustafsson, E., & Andersson, R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0515-5 · Cited by 44
“[27] demonstrated that delaying therapy for >44.”
BackgroundLathan, R., Sidapra, M., Yiasemidou, M., Long, J. A., Totty, J. P., Smith, G., & Chetter, I. C. (2022) · PLoS ONE · doi:10.1038/s41746-022-00655-0 · Cited by 43
Claeys, K. C., Lagnf, A. M., Hallesy, J. A., Compton, M., Gravelin, A. L., Davis, S. L., & Rybak, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02388-15 · Cited by 43
Self-citationForsblom, E., Aittoniemi, J., Ruotsalainen, E., Helmijoki, V., Huttunen, R., Jylhävä, J., Hurme, M., & Järvinen, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087741 · Cited by 43
“Delayed effective antimicrobial therapy has been reported to be one of the main risk factors for poor prognosis [37].”
BackgroundMoore, C. L., Lü, M., Cheema, F., Osaki-Kiyan, P., Perri, M. B., Donabedian, S. M., Haque, N. Z., & Zervos, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-11 · Cited by 43
“Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of bloodstream infection (BSI) and has been associated with mortality rates of between 20 and 30% (16, 18, 24, 30, 33).”
BackgroundStaphylococcus Aureus Pneumonia
Kollef, M. H., & Micek, S. T. (2005) · CHEST Journal · doi:10.1378/chest.128.3.1093 · Cited by 43
Lodise, T. P., Bonine, N. G., Ye, J. M., Folse, H. J., & Gillard, P. J. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4363-y · Cited by 42
“In addition to identifying variables that are independently associated with stronger odds of having the outcome of interest, the final logistic regression models are mathematic equations that can be used to predict the probability of antimicrobial resistance based on the combination of significant risk factors present…”
BackgroundSelf-citationUSA600 (ST45) Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Urban Detroit
Moore, C. L., Osaki-Kiyan, P., Perri, M. B., Donabedian, S. M., Haque, N. Z., Chen, A. L., & Zervos, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00409-10 · Cited by 42
“Pulsed-field gel electrophoresis (PFGE) analysis of 420 consecutive MRSA bloodstream isolates was performed, and 16 patients with USA600 MRSA BSIs were identified between July 2005 and July 2008 at a 900-bed tertiary care hospital in Detroit, MI (Fig.”
BackgroundResultInfluentialThe preSABATO study group*, Kaasch, A. J., Rieg, S., Kuetscher, J., Brodt, H. R., Widmann, T., Herrmann, M., Meyer, C., Welte, T., Kern, P., et al. (2013) · Infection · doi:10.1007/s15010-013-0428-9 · Cited by 42
Drusano, G. L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq253 · Cited by 41
Chen, S., Wang, J., Chen, T. H.-H., Lai, M., Chie, W., Chien, K., Hsueh, P., Wang, J., & Chang, S. (2010) · Medicine · doi:10.1097/md.0b013e3181f1851e · Cited by 41
“Studies examining the impact of inappropriate antibiotic therapy on S aureus bacteremia, however, have shown conflicting results.(24,33) In our previous study,(10) where we retrospectively analyzed the impact of early empirical glycopeptide therapy for 162 MRSA bacteremia patients, we found no statistical difference i…”
ResultEby, J. C., Richey, M. M., Platts-Mills, J. A., Mathers, A. J., Novicoff, W. M., & Cox, H. L. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix727 · Cited by 41
Vancomycin Revisited: A Reappraisal of Clinical Use
Cunha, B. A. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.012 · Cited by 41
Loading dose of vancomycin in critically ill patients: 15mg/kg is a better choice than 500mg
Mohammédi, I., Descloux, É., Argaud, L., LESCANFF, J., & Robert, D. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.009 · Cited by 41
Falcone, M., Micozzi, A., Pompeo, M. E., Baiocchi, P., Fabi, F., Penni, A., Martino, P., & Venditti, M. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.6.540 · Cited by 41
Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients
Álvarez, O., Plaza‐Plaza, J. C., Ramírez, M. M., Peralta, A. B., Amador, C. A., & Amador, R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-17 · Cited by 40
How to break the vicious circle of antibiotic resistances?
Léone, M., & Martin, C. (2008) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32830f1deb · Cited by 40
Staphylococcus aureus bacteraemia – Nationwide assessment of treatment adequacy and outcome
Ásgeirsson, H., Kristjánsson, M., Kristinsson, K. G., & Guðlaugsson, Ó. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.03.003 · Cited by 40
Moehring, R. W., Sloane, R. J., Chen, L. F., Smathers, E. C., Schmader, K. E., Fowler, V. G., Weber, D. J., Sexton, D. J., & Anderson, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076225 · Cited by 39
“In the few studies that have used time to appropriate therapy, the time period prior to blood culture collection was generally not discussed [32-34].”
BackgroundYoon, Y. K., Park, D. W., Sohn, J. W., Kim, H. Y., Kim, Y.-S., Lee, C.-S., Lee, M. S., Ryu, S.-Y., Jang, H.-C., Choi, Y. J., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1650-8 · Cited by 34
“1 %, which is comparable to the range from 29 % to 45 % reported in other studies [10, 12, 16, 36].”
ResultPeters, R. P. H., Twisk, J. W. R., van Agtmael, M. A., & Groeneveld, A. B. J. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01556.x · Cited by 38
“fants, although the latter application varies in accuracy [11,35–38].”
BackgroundClinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores
Park, S.-J., Son, J. S., Oh, I., Choi, J. M., & Lee, M. S. (2011) · Infection · doi:10.1007/s15010-011-0100-1 · Cited by 38
“In a previous analysis [24], MRSA infection was the most significant predictor of delayed treatment and delayed treatment was found to be an independent predictor of infection-related mortality.”
BackgroundChaubey, V. P., Pitout, J. D. D., Dalton, B., Gregson, D. B., Ross, T., & Laupland, K. B. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0647-4 · Cited by 38
“Several studies have found a clear relationship between time to first adequate therapy and mortality [9,30-32].”
BackgroundMethicillin-resistant Staphylococcus aureus infections in ICU patients
Sista, R. R., Oda, G., & Barr, J. (2004) · Anesthesiology Clinics of North America · doi:10.1016/j.atc.2004.04.006 · Cited by 38
Rapid Detection of Ampicillin Resistance in Escherichia coli by Quantitative Mass Spectrometry
Grundt, A., Findeisen, P., Miethke, T., Jäger, E., Ahmad‐Nejad, P., & Neumaier, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00047-12 · Cited by 37
“Immediate empirically based broad-spectrum antibiotic therapy is a cornerstone in treatment of sepsis (8, 9).”
BackgroundZheng, C., Zhang, S., Chen, Q., Zhong, L., Huang, T., Zhang, X., Zhang, K., Zhou, H., Cai, J., Du, L., et al. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00741-6 · Cited by 37
Saydain, G., Singh, J., Dalal, B., Yoo, W., & Levine, D. P. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.09.007 · Cited by 37
Maeda, M., Takuma, T., Haruka, S., Ugajin, K., Naito, Y., Yoshikawa, M., Yamanaka, A., Oto, Y., Minemura, A., Shoji, H., et al. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.11.004 · Cited by 37
Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants
Thaden, J. T., Ericson, J. E., Cross, H., Bergin, S. P., Messina, J. A., Fowler, V. G., Benjamin, D. K., Clark, R. H., Hornik, C. P. V., & Smith, P. B. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000850 · Cited by 36
“01 1000–1499 179 (25) 678 (26) 1500–2499 97 (13) 343 (13) 2500–3499 84 (12) 157 (6) >3500 41 (6) 52 (2) Age at positive blood culture, d <7 123 (17) 235 (9) <0.”
Emergency Department Vancomycin Use: Dosing Practices and Associated Outcomes
Fuller, B. M., Mohr, N. M., Skrupky, L. P., Mueller, K. L., & McCammon, C. (2012) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.09.036 · Cited by 36
Saeed, K. B. A., Dryden, M., Bourne, S., Paget, C., & Proud, A. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.03.018 · Cited by 36
Vancomycin Loading Doses: A Systematic Review
Reardon, J., Lau, T. T. Y., & Ensom, M. H. H. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015571163 · Cited by 36
Holmes, N. E., Robinson, J. O., van Hal, S. J., Munckhof, W., Athan, E., Korman, T. M., Cheng, A. C., Turnidge, J. D., Johnson, P. D. R., & Howden, B. P. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3011-2 · Cited by 37
“(positive blood cultures for SAB at time of death, death occurred before resolution of symptoms and signs of SAB, death occurred within 14 days after onset of SAB without another explanation, autopsy findings indicated SAB as cause of death, death certificated indicated SAB as cause of death) [3], longterm mortality a…”
BackgroundVancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock
Masich, A. M., Kalaria, S. N., Gonzales, J. P., Heil, E. L., Tata, A. L., Claeys, K. C., Patel, D. M., & Gopalakrishnan, M. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2367 · Cited by 35
IMPACT OF ANTIMICROBIAL RESISTANCE ON THE TREATMENT AND OUTCOME OF PATIENTS WITH SEPSIS
Costa, S. F. (2008) · Shock · doi:10.1097/shk.0b013e3181818990 · Cited by 35
“(19) MRSA Retrospective cohort 167 BSIs CART defined early therapy as G44.”
BackgroundThe search for new antimicrobials: why we need new options
Zinner, S. H. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.6.907 · Cited by 35
Emergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Kullar, R., Davis, S. L., Kaye, K. S., Levine, D. P., Pogue, J. M., & Rybak, M. J. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1220 · Cited by 34
Self-citationIncidence of community onset MRSA in Australia: least reported where it is Most prevalent
Cameron, J. K., Hall, L., Tong, S. Y. C., Paterson, D. L., & Halton, K. A. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0485-7 · Cited by 34
In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa
Pawar, V., Komor, U., Kasnitz, N., Bielecki, P., Pils, M. C., Gocht, B., Moter, A., Rohde, M., Weiß, S., & Häußler, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00194-15 · Cited by 34
Shime, N., Kosaka, T., & Fujita, N. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1024-x · Cited by 34
“Several studies have suggested that poorly chosen or delayed empiric treatments of bacteraemia due to MRSA or other microorganisms are associated with a significantly higher risk of fatal or nonfatal adverse outcomes [10, 11, 20 , 21].”
BackgroundOhashi, K., Matsuoka, T., Shinoda, Y., Fukami, Y., Shindoh, J., Yagi, T., Yoshimura, T., & Sugiyama, T. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13065 · Cited by 34
“032 YES 4/16 (25) CI, confidence interval; SIRS, systemic inflammatory response syndrome; SOFA, sequential organ failure assessment; CVC, central venous catheter; MRSA, methicillin- resistant Staphylococcus aureus; VCM, vancomycin; TEIC, teicoplanin.”
BackgroundInfluentialHo, K. M., & Robinson, J. O. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700320 · Cited by 34
How Long Does It Take to “Rule Out” Bacteremia in Children With Central Venous Catheters?
Shah, S. S., Downes, K. J., Elliott, M. R., Bell, L. M., McGowan, K. L., & Metlay, J. P. (2007) · PEDIATRICS · doi:10.1542/peds.2007-1387 · Cited by 34
Cassini, A., Plachouras, D., & Monnet, D. L. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30004-0 · Cited by 34
Chen, H., & Hsu, Y.-C. (2020) · Scientific Reports · doi:10.1038/s41598-020-64644-7 · Cited by 33
“Delayed antibiotics administration in bacteremic patients had been recognized as an independent risk factor of mortality(17,18).”
BackgroundMethodThe protective role of miR-223 in sepsis-induced mortality
Liu, D., Wang, Z., Wang, H., Ren, F., Li, Y., Zou, S., Xu, J., & Xie, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-74965-2 · Cited by 33
Lim, S. Y., Pannikath, D., & NUGENT, K. M. (2015) · Rheumatology International · doi:10.1007/s00296-014-3206-9 · Cited by 33
Laboratory diagnosis of late-onset sepsis in newborns by multiplex real-time PCR
Paolucci, M., Capretti, M. G., Monte, P. D., Corvaglia, L., Landini, M. P., Varani, S., Pession, A., Faldella, G., & Sambri, V. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.003848-0 · Cited by 33
“Early diagnosis of sepsis and prompt treatment are critical in preventing severe and life-threatening complications in these patients (Harbarth et al., 2003; Kollef, 2003; Lodise et al., 2003).”
BackgroundMajidpour, A., Zadeh, S. F., Afshar, M., Rahbar, M., Boustanshenas, M., Heidarzadeh, M., Arbabi, L., & Moghadam, S. S. (2017) · Iranian journal of pathology · doi:10.30699/ijp.2017.27993 · Cited by 33
“Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and-negative clinical isolates of Staphylococcus epidermidis.”
BackgroundTurnidge, J. D., Nimmo, G. R., Pearson, J. C., Gottlieb, T., Collignon, P., & Australian Group on Antimicrobial Resistance (2007) · Communicable Diseases Intelligence · doi:10.33321/cdi.2007.31.43 · Cited by 33
Mahrous, A. J., Thabit, A. K., Elarabi, S., & Fleisher, J. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.09.010 · Cited by 32
Ellis, J. M., Kuti, J. L., & Nicolau, D. P. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.007 · Cited by 32
Antibiotic Utilization Improvement with the Nanosphere Verigene Gram-Positive Blood Culture Assay
Beal, S. G., Thomas, C., Dhiman, N., Nguyen, D., Qin, H., Hawkins, J. M., Dekmezian, M. S., Benavides, R., & Njoku, J. (2015) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2015.11929214 · Cited by 31
“Lodise et al (11) reported that delayed treatment (>44.75 hours from the time the culture result was available) of Staphylococcus aureus bacteremia led to a 7-day longer hospital stay (20.2 days vs. 14.3 days; P = 0.05) and was an independent predictor of infection-related mortality.”
BackgroundInfluentialZasowski, E. J., Trinh, T. D., Claeys, K. C., Lagnf, A. M., Bhatia, S., Klinker, K. P., Veve, M. P., Estrada, S., Johns, S. T., Sawyer, A., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab606 · Cited by 31
“Data suggest that the initial 24–48 hours of MRSA BSI therapy is most strongly associated with outcome [34, 38].”
Self-citationGeorge, N. A., Pan, D., Silva, L., Baggaley, R. F., Irizar, P., Divall, P., Al‐Oraibi, A., Khan, D. P., Martin, C., Nazareth, J., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103384 · Cited by 30
Lewis, T., Chaudhry, R., Nightingale, P., Lambert, P. A., & Das, I. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.09.013 · Cited by 31
“One of the reasons for this discrepancy may be that delays in empirical therapy have most impact in severely unwell patients.(24) In our study, in patients with MRSA bacteremia who had signs of severe sepsis, a delay in starting an antibiotic active against MRSA was associated with a higher mortality.”
BackgroundScanvic, A., Courdavault, L., Sollet, J.-P., & Turdu, F. L. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.07.016 · Cited by 30
Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever
Stryjewski, M. E., Kanafani, Z. A., Chu, V. H. Y., Pappas, P. A., Harding, T. M., Drew, L. A., Benjamin, D. K., Reller, L. B., Lee, B. A., Corey, G. R., et al. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.040 · Cited by 30
Patel, N., VanDeWall, H., Tristani, L., Rivera, A., Woo, B., Dihmess, A., Li, H. K., Smith, R. P., & Lodise, T. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr522 · Cited by 30
Self-citationLi, L., Chen, J., Ouyang, B., Chen, M., Guan, X., & Zhu, Z. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318253a1a6 · Cited by 30
“The lack of specific clinical indicators for sepsis along with the complexity and heterogeneity of the host response to infection frequently lead to delayed diagnosis, which in turn results in ineffective and belated antimicrobial treatment.(5,6) Therefore, it is highly desirable to find sensitive and specific indicat…”
BackgroundBennett, K., & Sharp, S. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01276-08 · Cited by 30
“Appropriately and rapidly treating a patient with the most effective antibiotic will decrease complications for the patient, reduce the length of hospital stay for the patient, and decrease patient morbidity and mortality, resulting in increased savings for medical institutions (10, 14, 15, 18).”
BackgroundHung, Y.-P., Lee, C.-C., & Ko, W.-C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.869822 · Cited by 29
Daptomycin for the treatment of surgical site infections
Chamberlain, R. S., Culshaw, D. L., Donovan, B. J., & Lamp, K. C. (2009) · Surgery · doi:10.1016/j.surg.2009.03.037 · Cited by 29
Lima, D. F., Brazão, N. B. V., Folescu, T. W., Neves, F. P. G., Ferreira, A. G., Santos, E. A. D. O., Marques, E. A., & Leão, R. S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.10.004 · Cited by 29
“Acquisition of this organism is typically associated with particular settings and patient groups (Health Care Associated MRSA, HAMRSA) (Lodise et al., 2003).”
BackgroundLodise, T. P., Miller, C., Patel, N., Graves, J. P., & McNutt, L. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518972 · Cited by 29
Self-citationSmith, J. R., Frens, J. J., Snider, C. B., & Claeys, K. C. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.10.001 · Cited by 29
Napolitano, L. M. (2008) · Surgical Infections · doi:10.1089/sur.2008.063.supp · Cited by 29
“Appropriate treatment was delayed in these episodes because patients were treated initially with an antibiotic that lacked activity against the MRSA strain [8].”
Rapid Microbial Sample Preparation from Blood Using a Novel Concentration Device
Boardman, A. K., Campbell, J., Wirz, H., Sharon, A., & Sauer-Budge, A. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116837 · Cited by 28
“Appropriate patient care requires the assessment of this condition as quickly and precisely as possible [1].”
Holmes, N. E., Turnidge, J. D., Munckhof, W., Robinson, J. O., Korman, T. M., O'Sullivan, M. V. N., Anderson, T. L., Roberts, S., Warren, S. J. C., Gao, W., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12168 · Cited by 28
“[3].”
Hospital rules-based system: The next generation of medical informatics for patient safety
Wilson, J. W., Oyen, L. J., Ou, N. N., McMahon, M. M., Thompson, R. L., Manahan, J. M., Graner, K. K., Lovely, J. K., & Estes, L. L. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.5.499 · Cited by 28
Guido, M., Quattrocchi, M. R., Zizza, A., Pasanisi, G., Pavone, V., Lobreglio, G., Gabutti, G., & De Donno, M. A. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2012.53.2.326 · Cited by 27
“In recent years, the incidence of sepsis is increasing and the diagnosis in neutropenic patients and, more generally immunocompromised, remains a challenge as approximately half of sepsis cases are culture negative [15].”
BackgroundSamura, M., Kitahiro, Y., Tashiro, S., Moriyama, H., Hamamura, Y., Takahata, I., Kawabe, R., Enoki, Y., Taguchi, K., Takesue, Y., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040714 · Cited by 27
“was assigned to one of three categories, as described for previous studies [24,25]: lowrisk sources (mortality < 10%) included intravenous catheter, urinary tract, ear–nose– larynx, gynecological, and various manipulation-related sources; intermediate-risk sources (mortality 10–20%) included osteoarticular, soft tissu…”
MethodInfective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
del Val, D., Abdel‐Wahab, M., Mangner, N., Durand, É., Ihlemann, N., Ureña, M., Pellegrini, C., Giannini, F., Gąsior, T., Wojakowski, W., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.10.004 · Cited by 26
“694 Time to surgery, median (IQR), days 17 (7-37) 11.”
Forsblom, E., Ruotsalainen, E., & Järvinen, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122824 · Cited by 26
Ásgeirsson, H., Guðlaugsson, Ó., Kristinsson, K. G., Vilbergsson, G. R., Heiðdal, S., Haraldsson, Á., Weiland, O., & Kristjánsson, M. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000485 · Cited by 26
Venet, M., Jalal, Z., Ly, R., Malekzadeh-Milani, S. G., Hascoët, S., Fournier, E., Ovaert, C., Casalta, A., Karsenty, C., Baruteau, A., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.07.015 · Cited by 25
Lee, S. H., Cha, B., Yi, H., Kim, J., Jeon, J. S., & Park, J. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136161 · Cited by 25
Bamberger, D. M. (2007) · PubMed Central · Cited by 25
Clinical and molecular epidemiology of nursing home–associated Staphylococcus aureus bacteremia
Lesse, A. J., & Mylotte, J. M. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.06.008 · Cited by 25
Park, K., Lee, Y., Hong, H., Kim, T., Park, H. J., Park, S.-Y., Moon, S. M., Chong, Y. P., Kim, S., Lee, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046389 · Cited by 24
“aureus at the time of death or if death occurred before resolution of the signs and symptoms of SAB without another explanation [8].”
BackgroundDeRyke, C. A., Maglio, D., & Nicolau, D. P. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.6.873 · Cited by 23
“[91] performed a retrospective study evaluating the impact of delay in appropriate empiric treatment on clinical outcomes in patients who developed nosocomial S.”
BackgroundRomero‐Gómez, M. P., Quiles‐Melero, I., Navarro, C., Paño‐Pardo, J. R., Gómez-Gil, R., & Mingorance, J. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.11.012 · Cited by 24
Walker, S. A. N., de Vijsel, L. M. V., Walker, S. E., Yamashita, S. K., Simor, A. E., & Hladunewich, M. (2010) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v63i3.915 · Cited by 24
“infections is significantly increased when there is a delay in the administration of appropriate antimicrobial therapy.(2-7) Data”
BackgroundHu, H., Kao, K., Chiu, L., Chang, C., Hung, C., Li, L., Liu, T.-P., Lin, L.-C., Chen, N., Huang, C.-C., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1215-2 · Cited by 24
“Mortality was considered to be attributable to MRSA bacteremia if blood cultures were positive for MRSA at the time of death, or if death occurred before the resolution of the signs and symptoms of MRSA infection or if death occurred within 14 days after the onset MRSA bacteremia without another explanation [17].”
BackgroundMonsel, A., Lécart, S., Roquilly, A., Broquet, A. H., Jacqueline, C., Mirault, T., Troude, T., Fontaine‐Aupart, M., & Asehnoune, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092564 · Cited by 24
Chung, Y., Kim, T. S., Min, Y. G., Hong, Y. J., Park, J. S., Hwang, S. M., Song, K., Kim, E. S., Park, K. U., Kim, H. B., et al. (2016) · BioMed Research International · doi:10.1155/2016/6913860 · Cited by 24
“aureus (MRSA) infections result in significant morbidity, mortality, and longer hospital stays if not treated early with effective antibiotics [3].”
BackgroundHida, Y., Uemura, K., Sugimoto, H., Kawashima, Y., Koyanagi, N., Notake, S., Akashi, Y., Sakaguchi, S., Kimura, H., & Suzuki, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219819 · Cited by 24
Furuno, J. P., Harris, A. D., Wright, M., Hartley, D., McGregor, J. C., Gaff, H. D., Hebden, J. N., Standiford, H. C., & Perencevich, E. N. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518348 · Cited by 24
Aratani, T., Tsukamoto, H., Higashi, T., Kodawara, T., Yano, R., Hida, Y., Iwasaki, H., & Goto, N. (2021) · Journal of International Medical Research · doi:10.1177/03000605211058872 · Cited by 23
“In other studies, the time to initiation of appropriate antibiotic treatment was defined either as the time since a positive blood culture was reported or the time after bacteremia had developed.(12,15) In the current study, multivariate analysis was performed using appropriate antibiotic treatment within 24 hours of…”
MethodYossepowitch, O., Dan, M., Kutchinsky, A., Gottesman, T., & Schwartz–Harari, O. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.01.001 · Cited by 23
“Any delay in appropriate antibiotic treatment, even a delay of no more than 48 hours, is an independent predictor of longer hospital stay, infection-related mortality, and secondary infectious complications (such as endocarditis and vertebral osteomyelitis) (Lodise et al., 2003; Paul et al., 2010).”
BackgroundQian, Q., Venkataraman, L., Kirby, J. E., Gold, H. S., & Yamazumi, T. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01517-09 · Cited by 23
“Staphylococcus aureus is the leading cause of bloodstream infections, with high levels of morbidity and mortality arising from complications (7, 9, 19).”
Background
Metadata
- Authors
- Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J.
- Affiliations
- Detroit Receiving Hospital (US)
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Corresponding author
- McKinnon, Peggy S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1418-1423
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102463930
- Cited by
- 604
- References
- 24
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 28 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 19 · 2015: 40 · 2014: 26 · 2013: 37 · 2012: 31
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- Staphylococcus aureus bacteremia, nosocomial infections, delayed antibiotic treatment, mortality, length of hospital stay, treatment timing, classification and regression trees
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Cohort Studies, Methicillin Resistance, Bacteremia, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.